02 March 2018 | News
Predible Health facilitates cancer diagnosis through its artificial intelligence powered clinical applications for liver and lung cancers.
Image credit- express.co.uk
Artificial Intelligence (AI)-based cancer radiology platform Predible Health has raised an undisclosed amount of funding from Unitus Seed Fund. Predible Health plans to use the funds to scale its cancer AI platform as well as invest in regulatory approvals for its existing products.
Predible Health facilitates cancer diagnosis through its artificial intelligence powered clinical applications for liver and lung cancers which enable radiologists to interpret images faster and with more accuracy. It has developed algorithms to help physicians characterise diseases as well as plan and deliver personalised treatment.
The startup has developed two flagship products, including Predible Liver, which assists surgeons with precise planning for liver transplant and tumour resections through instant analysis and 3D visualisation of liver lesions and hepatic structures. Built on the cloud, the solution can be accessed by hospitals across India with an internet connection.